Cleared Traditional

K220047 - AcQCross Qx Integrated Transseptal Dila...

K220047 is the FDA 510(k) clearance for AcQCross Qx Integrated Transseptal Dila... by Acutus Medical, Inc.. It is a Class 2 Cardiovascular device (product code DYB) cleared through the Traditional 510(k) pathway after a 34-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
34d
Days
Class 2
Risk

K220047 is an FDA 510(k) clearance for the AcQCross Qx Integrated Transseptal Dilator/Needle. Classified as Introducer, Catheter (product code DYB), Class II - Special Controls.

Submitted by Acutus Medical, Inc. (Carlsbad, US). The FDA issued a Cleared decision on February 8, 2022 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Acutus Medical, Inc. devices

Submission Details

510(k) Number K220047 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 2022
Decision Date February 08, 2022
Days to Decision 34 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 125d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DYB Introducer, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DYB Introducer, Catheter

All 391
Devices cleared under the same product code (DYB) and FDA review panel - the closest regulatory comparables to K220047.
Dib UltraNav Transseptal Catheter System
K213492 · Dib Ultranav Medical, LLC · Mar 2022
PathBuilder Transseptal Guiding Introducer
K212626 · Shanghai Microport EP Medtech Co., Ltd. · Mar 2022
PathBuilder Steerable Introducer
K211530 · Shanghai Microport EP Medtech Co., Ltd. · Feb 2022
Prelude IDeal 9F Hydrophilic Sheath Introducer
K212152 · Merit Medical Systems · Jan 2022
Traveler 0.038 Stylet Portal Vein Access (TPS001), Traveler 21ga Needle Portal Vein Access Set (TPS002), Traveler 16ga Needle Portal Vein Access Set (TPS003)
K213638 · Argon Medical Devices · Dec 2021
SCORPION Portal Vein Access Set
K213002 · Argon Medical Devices · Oct 2021